Glucose management

Glucose management

Care300® is a patented organic standardised mango fruit powder (Mangifera indica spp Totapuri). Care300® activates the key metabolic enzymes SIRT1 and AMPK, improving metabolism and glucose tolerance. Supported with 1 published clinical trial. 300 mg/day.

Care300® - Key features

  • Patented ingredient

  • Plays a role in the activation of SIRT1 and AMPK for glucose uptake

  • Efficient on insulin sensitivity

  • Protects metabolism homeostasis (SOD, inflammatory markers)

  • Significant improvement in glucose levels after 1 month

Science supporting Care300®

Care300® improves glucose management. Its mechanism of action in SIRT1 and AMPK modulation has been analysed in in-vitro studies. Its benefits have been confirmed in a chronic gold-standard clinical study.


Care300® is a standardised whole fruit powder of mango Mangifera indica L. obtained from the subspecies Totapuri (a.k.a. Kili-Mooku). It is cultivated in the Tamil Nadu region of India, at a specific degree of maturity, when the content of secondary plant compounds is high.

Bioactive compounds
  Mangiferin                 ≥ 0.03%

Composition: Mango fruit powder (Mangifera indica (L.) spp. Totapuri)

Recommended daily dosage: 300 mg/day

Mechanism of action

Care300® modulates SIRT1.  

Sirtuin 1 (SIRT1) is a key master switch enzyme for energy homeostasis and cellular metabolism, cell protection, and longevity by increased mitochondrial metabolism, thermogenesis, and antioxidant protection.

Caloric restriction or physical exercises activate SIRT1, physiologically.


Care300® activates AMPK.

AMPK is an enzyme that plays a role in cellular energy homeostasis, largely to activate glucose and fatty acid uptake and oxidation when cellular energy is low.

  • All three batches of Mangifera indica L. fruit powder showed reproducible activation of AMPK.
  • Care300® is able to activate AMPK by more than 50%.
  • Mangiferin is one of the actives in Care300® contributing to AMPK activation.

Care300® provides antioxidant and anti-inflammatory effects.

  • Care300® stimulates SOD (superoxide dismutase) by more than 45%.
  • Care300® has anti-inflammatory effect by inhibition of IL-6, TNF-alpha release and COX 1 / 2 activity.

Care300® regulates fasting glucose and insulin.

Care300® normalised fasting glucose levels to NFC levels with lower fasting insulin levels, providing protection against this high-fat diet-induced increase in insulin resistance as reflected in the statistically significant reduction in the HOMA-IR score between T2 and HF control groups.

Care300® significantly improved HOMA-IR index, an index for insulin sensitivity.

Clinically supported benefits

Double-blind, randomised, placebo-controlled studies.


BioTeSys GmbH, Germany


4 weeks


75 subjects
Women and men
BMI 19-30 kg/m2
Age: 40-70 years old


Oral glucose tolerance test (OGTT)
Endothelial function

300 mg/day of Care300 in water 

Care300® improves glucose tolerance.

OGTT was performed to identify volunteers with early-stage impaired glucose tolerance and to investigate the effect of Care300® on glucose tolerance.

Supplementation with Care300® supported the subjects with a better adaptation.

Care300® significantly improves glycated hemoglobin.

Glycated hemoglobin, reflecting blood glucose value over the long-term, decreased significantly with Care300® supplementation.

Care300® is safe.

No adverse event linked to Care300® supplementation has been recorded.

Regulatory & Certifications

Organic certified
Non-GMO, Halal, Kosher, gluten-free, suitable for vegetarians


Röchter S. et al. Agro Food Industry Hi-Tech. 2015; Vol. 26(3)
Gerstgrasser et al., Planta Med, 2015; 82(4), 298-304
Sabater G. A. et al. Cell Physiol Biochem. 2017; 42:564-578

Buchwald-Werner S. et al. Planta Med. 2017; 83(10): 824-829

This website is intended to provide information about Fytexia’s ingredients, used in various food/dietary supplement products around the world. It is only intended for business to business and to provide information to food/dietary supplement professionals and is not designed for the general public.  Statements used on this website have not been evaluated by the Food and Drug Administration or any other competent authority. Products are not intended to diagnose, treat, cure or prevent any disease.